Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	21,133	20,433	18,363	22,073	27,883	44,467
Market Cap Growth	26.61%	11.28%	-16.81%	-20.84%	-37.29%	65.66%
Enterprise Value	23,341	22,733	20,749	25,782	28,964	44,979
Last Close Price	217.20	209.15	187.23	237.01	297.92	473.53

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	72.16	76.93	104.87	71.14	31.83	107.31
Forward PE	39.54	40.98	46.49	49.64	31.48	60.28
PS Ratio	7.03	6.89	6.61	7.95	7.98	15.40
PB Ratio	4.98	4.95	4.56	8.26	11.09	25.66
P/TBV Ratio	-	-	-	-	46.41	163.54
P/FCF Ratio	53.60	68.34	38.63	80.91	153.46	117.67
P/OCF Ratio	26.79	29.52	22.53	29.57	45.54	63.35
PEG Ratio	2.44	1.86	2.29	6.24	1.67	6.53

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	7.77	7.66	7.46	9.29	8.29	15.58
EV/EBITDA Ratio	27.79	29.22	32.97	39.20	24.20	43.61
EV/EBIT Ratio	41.02	42.25	52.40	54.93	27.47	48.88
EV/FCF Ratio	59.20	76.03	43.65	94.51	159.41	119.02

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.57	0.63	0.71	1.38	0.45	0.36
Debt / EBITDA Ratio	2.85	3.23	4.38	5.39	0.93	0.60
Debt / FCF Ratio	6.09	8.69	6.04	13.50	6.25	1.66
Net Debt / Equity Ratio	0.52	0.53	0.54	1.33	0.40	0.23
Net Debt / EBITDA Ratio	2.69	2.78	3.47	5.41	0.84	0.38
Net Debt / FCF Ratio	5.58	7.24	4.59	13.03	5.52	1.03
Asset Turnover	0.37	0.37	0.35	0.43	0.78	0.85
Inventory Turnover	2.35	2.36	2.01	1.62	1.85	2.13
Quick Ratio	0.48	0.47	1.05	0.49	0.53	0.59
Current Ratio	1.16	1.02	1.85	1.51	1.61	1.40
Return on Equity (ROE)	7.09%	6.53%	5.33%	12.05%	41.43%	25.94%
Return on Assets (ROA)	4.40%	4.14%	3.10%	4.59%	14.62%	16.90%
Return on Invested Capital (ROIC)	6.44%	6.14%	5.19%	7.49%	29.10%	28.75%
Return on Capital Employed (ROCE)	8.50%	8.20%	5.40%	6.90%	26.20%	31.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.38%	1.30%	0.95%	1.41%	3.14%	0.93%
FCF Yield	1.87%	1.46%	2.59%	1.24%	0.65%	0.85%
Dividend Yield	0.32%	0.33%	0.37%	0.29%	0.48%	0.27%
Payout Ratio	22.93%	25.26%	38.32%	42.77%	13.25%	15.13%
Buyback Yield / Dilution	0.19%	-0.54%	-5.01%	0.00%	0.01%	0.00%
Total Shareholder Return	0.50%	-0.21%	-4.64%	0.29%	0.50%	0.27%

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error